The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Who dares wins fustration with shareholders think trevor owes to us to ne more transparrent but he gonna give sniff to when payout is waits to people to fold then in for kill but we bedn thick and thin overbyears on this share got have brave heart for this share good luck to folders
Sileng take it u are not invested or lost a lot its one of two we hsve limted shares if dont serl test sell it worldwide could reach billion in sales not net profit so stop puttin share down invest somthing else these products are not in markert yet not even sold do dont know wot tslkin about last frb 1.50 specultion alone these will go to 5 pound u be crying
The test is gold and THATS WOT LIES AHEAD A MUTIBAGGER qestion of when as warren buffet says be patientt anno its hard because tests could make into billion if worldwide hope CE IS APPROVED stick with it be good to see what next rns is fingers crossed shareholders
Helm now is perfect opptuinty to top up only going north as gorden ghecko said greed os good this company will take u there beilive in possible to much negtivity from share holders people need suspenders on pants grow up lads see bog picture top up go north
Great news for phase foucus and dale ftom this be exciting coming months as for covid test and sepsis boom boom are test is great as virial load can be tested so mutations will be dectected im confident with this test and media exposure from sheffield phase focus be in most uni selling and were come the dividends be great to see this at 5.00 pound coming months
https://www.nbcnews.com/health/health-news/why-do-covid-rapid-tests-cost-so-much-even-after-n1278934 flying of shelves be great divendend if he sells on boy